An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity

Drug hypersensitivity may manifest ranging from milder skin reactions (e.g., maculopapular exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS), or Stevens–Johnson synd...

Full description

Saved in:
Bibliographic Details
Main Authors: Chun-Bing Chen, Riichiro Abe, Ren-You Pan, Chuang-Wei Wang, Shuen-Iu Hung, Yi-Giien Tsai, Wen-Hung Chung
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/6431694
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553184310067200
author Chun-Bing Chen
Riichiro Abe
Ren-You Pan
Chuang-Wei Wang
Shuen-Iu Hung
Yi-Giien Tsai
Wen-Hung Chung
author_facet Chun-Bing Chen
Riichiro Abe
Ren-You Pan
Chuang-Wei Wang
Shuen-Iu Hung
Yi-Giien Tsai
Wen-Hung Chung
author_sort Chun-Bing Chen
collection DOAJ
description Drug hypersensitivity may manifest ranging from milder skin reactions (e.g., maculopapular exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS), or Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Current pharmacogenomic studies have made important strides in the prevention of some drug hypersensitivity through the identification of relevant genetic variants, particularly for genes encoding drug-metabolizing enzymes and human leukocyte antigens (HLAs). The associations identified by these studies are usually drug, phenotype, and ethnic specific. The drug presentation models that explain how small drug antigens might interact with HLA and T cell receptor (TCR) molecules in drug hypersensitivity include the hapten theory, the p-i concept, the altered peptide repertoire model, and the altered TCR repertoire model. The broad spectrum of clinical manifestations of drug hypersensitivity involving different drugs, as well as the various pathomechanisms involved, makes the diagnosis and management of it more challenging. This review highlights recent advances in our understanding of the predisposing factors, immune mechanisms, pathogenesis, diagnostic tools, and therapeutic approaches for drug hypersensitivity.
format Article
id doaj-art-3fc64c4caaec44b29d464d6cc069aac0
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-3fc64c4caaec44b29d464d6cc069aac02025-02-03T05:54:41ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/64316946431694An Updated Review of the Molecular Mechanisms in Drug HypersensitivityChun-Bing Chen0Riichiro Abe1Ren-You Pan2Chuang-Wei Wang3Shuen-Iu Hung4Yi-Giien Tsai5Wen-Hung Chung6Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou, Keelung, TaiwanDivision of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, JapanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou, Keelung, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou, Keelung, TaiwanDepartment and Institute of Pharmacology, School of Medicine, Infection and Immunity Research Center, National Yang-Ming University, Taipei, TaiwanDivision of Pediatric Allergy and Immunology, Changhua Christian Hospital, Changhua City, TaiwanDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou, Keelung, TaiwanDrug hypersensitivity may manifest ranging from milder skin reactions (e.g., maculopapular exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS), or Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Current pharmacogenomic studies have made important strides in the prevention of some drug hypersensitivity through the identification of relevant genetic variants, particularly for genes encoding drug-metabolizing enzymes and human leukocyte antigens (HLAs). The associations identified by these studies are usually drug, phenotype, and ethnic specific. The drug presentation models that explain how small drug antigens might interact with HLA and T cell receptor (TCR) molecules in drug hypersensitivity include the hapten theory, the p-i concept, the altered peptide repertoire model, and the altered TCR repertoire model. The broad spectrum of clinical manifestations of drug hypersensitivity involving different drugs, as well as the various pathomechanisms involved, makes the diagnosis and management of it more challenging. This review highlights recent advances in our understanding of the predisposing factors, immune mechanisms, pathogenesis, diagnostic tools, and therapeutic approaches for drug hypersensitivity.http://dx.doi.org/10.1155/2018/6431694
spellingShingle Chun-Bing Chen
Riichiro Abe
Ren-You Pan
Chuang-Wei Wang
Shuen-Iu Hung
Yi-Giien Tsai
Wen-Hung Chung
An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
Journal of Immunology Research
title An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
title_full An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
title_fullStr An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
title_full_unstemmed An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
title_short An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
title_sort updated review of the molecular mechanisms in drug hypersensitivity
url http://dx.doi.org/10.1155/2018/6431694
work_keys_str_mv AT chunbingchen anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT riichiroabe anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT renyoupan anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT chuangweiwang anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT shueniuhung anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT yigiientsai anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT wenhungchung anupdatedreviewofthemolecularmechanismsindrughypersensitivity
AT chunbingchen updatedreviewofthemolecularmechanismsindrughypersensitivity
AT riichiroabe updatedreviewofthemolecularmechanismsindrughypersensitivity
AT renyoupan updatedreviewofthemolecularmechanismsindrughypersensitivity
AT chuangweiwang updatedreviewofthemolecularmechanismsindrughypersensitivity
AT shueniuhung updatedreviewofthemolecularmechanismsindrughypersensitivity
AT yigiientsai updatedreviewofthemolecularmechanismsindrughypersensitivity
AT wenhungchung updatedreviewofthemolecularmechanismsindrughypersensitivity